Emmessar Biotech & Nutrition Reports Standalone Net Loss Of Rs 0.07 Crore In The March 2025 Quarter

24-Apr-25   15:09 Hrs IST
Net loss of Emmessar Biotech & Nutrition reported to Rs 0.07 crore in the quarter ended March 2025 as against net profit of Rs 0.27 crore during the previous quarter ended March 2024. Sales rose 25.00% to Rs 0.10 crore in the quarter ended March 2025 as against Rs 0.08 crore during the previous quarter ended March 2024.

For the full year,net profit declined 50.77% to Rs 0.32 crore in the year ended March 2025 as against Rs 0.65 crore during the previous year ended March 2024. Sales rose 8.93% to Rs 0.61 crore in the year ended March 2025 as against Rs 0.56 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales0.100.08 25 0.610.56 9
OPM %-330.00-487.50 --155.74-192.86 -
PBDT0.280.09 211 1.060.91 16
PBT0.260.07 271 0.960.81 19
NP-0.070.27 PL 0.320.65 -51

Powered by Capital Market - Live News

Trade, Track, Thrive!

Experience insight with every swipe.

Open your Chola Securities account in minutes and start trading across stocks, derivatives, mutual funds, and more — all in one place.

Start Investing Now →
Trading App Screen
We are hiring! Check out open positions and send your CV to csecrecruit@chola.murugappa.com
Pre-Apply for IPOs
Chola Securities App
Install
🌐
Stay on Web